{"id":5165,"date":"2025-03-27T14:11:52","date_gmt":"2025-03-27T13:11:52","guid":{"rendered":"https:\/\/schizophrenia.life\/public\/?page_id=5165"},"modified":"2025-03-27T14:11:52","modified_gmt":"2025-03-27T13:11:52","slug":"sod-chapter-2","status":"publish","type":"page","link":"https:\/\/schizophrenia.life\/public\/sod-chapter-2\/","title":{"rendered":"Chapter 2"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full square-image\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"298\" src=\"https:\/\/schizophrenia.life\/public\/wp-content\/uploads\/2025\/09\/Hero_Chpt2.jpg\" alt=\"\" class=\"wp-image-5961\" srcset=\"https:\/\/schizophrenia.life\/public\/wp-content\/uploads\/2025\/09\/Hero_Chpt2.jpg 300w, https:\/\/schizophrenia.life\/public\/wp-content\/uploads\/2025\/09\/Hero_Chpt2-150x150.jpg 150w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"lh-n mb-2 mt-1 has-text-color has-link-color wp-elements-8f21297560bd8ed80774138e52b46fe3 wp-block-paragraph\" style=\"color:#e3ce6f;font-size:46px\"><strong><strong>Chapter 2<\/strong><\/strong><\/p>\n\n\n\n<p class=\"lh-n mb-2 mt-1 has-text-color has-link-color has-large-font-size wp-elements-3f69d09eb9fa70f34a2b831ae48a4dee wp-block-paragraph\" style=\"color:#e3ce6f\"><strong>Facing dual challenge<\/strong><\/p>\n\n\n\n<p class=\"mb-0 has-text-color has-link-color wp-elements-2b99aab0e196f54eb490b87b9b7529d0 wp-block-paragraph\" style=\"color:#58595b;font-size:16px\">This chapter highlights the key clinical aspects of schizophrenia and substance use disorders, with a focus on their co-occurrence and the challenges they present, and the importance of integrated therapies that address both illnesses.<\/p>\n\n\n\n<p class=\"has-text-align-center button__primary button-text sod-subchapter-button-e3ce6f wp-block-paragraph\"><a href=\"\/public\/wp-content\/uploads\/2025\/09\/02_Candid-Book-2_Chapter-2.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Download the chapter<\/a><\/p>\n<\/div>\n<\/div>\n\n\n<\/div><\/div><\/div><\/div><div class=\"sod_highlight py-4\"><div class=\"rea-main rea-page-default\"><div class=\"rea-page-default__wrapper my-0\"><div class=\"entry-content\">\n\n\n\n<p class=\"has-text-color has-link-color wp-elements-1f799f44333af2c6f2bc5fdbb61bd9f5 wp-block-paragraph\" style=\"color:#e3ce6f;font-size:26px\"><strong>Fast Facts<\/strong><\/p>\n\n\n\n<p class=\"sod-border-left-e3ce6f mb-5 has-text-color has-link-color wp-elements-4c690244d7b01fc797f86fb406e45a8b wp-block-paragraph\" style=\"color:#58595b\"><mark style=\"background-color:rgba(0, 0, 0, 0);color:#e3ce6f\" class=\"has-inline-color\"><strong>Early onset<\/strong>:<\/mark> People with schizophrenia 43 and a history of substance use are in the attention of psychiatric services earlier than those without such a history.<\/p>\n\n\n\n<p class=\"sod-border-left-e3ce6f mb-5 has-text-color has-link-color wp-elements-54f9804d6b78b49fd0da4c387ee2574f wp-block-paragraph\" style=\"color:#58595b\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#e3ce6f\" class=\"has-inline-color\">Dual challenge:<\/mark><\/strong> When schizophrenia and substance use disorder coexist, they create a more challenging clinical picture and lead to poorer outcomes than either condition alone.<\/p>\n\n\n\n<p class=\"sod-border-left-e3ce6f mb-5 has-text-color has-link-color wp-elements-ca631fef83839b80eff3480cb7bf47f3 wp-block-paragraph\" style=\"color:#58595b\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#e3ce6f\" class=\"has-inline-color\">Many people with schizophrenia underreport their substance use<\/mark><\/strong>, often out of fear of judgment or blame. Recognizing substance use disorder as a mental health condition, not a choice, is key to providing better support and care.<\/p>\n\n\n\n<p class=\"sod-border-left-e3ce6f mb-5 has-text-color has-link-color wp-elements-d9284cde13d450d1b568946d877def43 wp-block-paragraph\" style=\"color:#58595b\"><mark style=\"background-color:rgba(0, 0, 0, 0);color:#e3ce6f\" class=\"has-inline-color\"><strong>Integrated treatment<\/strong>:<\/mark> Effective care for dual schizophrenia must address both schizophrenia symptoms and symptoms related to substance use disorder to improve recovery and long-term outcomes.<\/p>\n\n\n<\/div><\/div><\/div><\/div><div class=\"rea-main rea-page-default\"><div class=\"rea-page-default__wrapper\"><div class=\"\"><div class=\"entry-content\">\n\n\n\n<div class=\"wp-block-columns mt-7 is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column sod-column sod-column-e3ce6f is-layout-flow wp-block-column-is-layout-flow\">\n<a href=\"\/public\/sod-chapter-2-subchapter-1\">\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"212\" src=\"https:\/\/schizophrenia.life\/public\/wp-content\/uploads\/2025\/09\/2.1.jpg\" alt=\"\" class=\"wp-image-6056\"\/><\/figure>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-c0fc3766b0753d15ffc315fd40e3c1d8 wp-block-paragraph\" style=\"font-size:16px\"><strong>Subchapter 1.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"font-size:16px\">The vicious circle, in which schizophrenia and substance use disorders exacerbate each other<\/p>\n\n\n\n<\/a>\n<\/div>\n\n\n\n<div class=\"wp-block-column sod-column sod-column-e3ce6f is-layout-flow wp-block-column-is-layout-flow\">\n<a href=\"\/public\/sod-chapter-2-subchapter-2\">\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"212\" src=\"https:\/\/schizophrenia.life\/public\/wp-content\/uploads\/2025\/09\/2.2.jpg\" alt=\"\" class=\"wp-image-6057\"\/><\/figure>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-666f6b946fde8a0ec22ce4e7167c70c9 wp-block-paragraph\" style=\"font-size:16px\"><strong>Subchapter 2.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"font-size:16px\">Early substance use in high-risk adolescents<\/p>\n\n\n\n<\/a>\n<\/div>\n\n\n\n<div class=\"wp-block-column sod-column sod-column-e3ce6f is-layout-flow wp-block-column-is-layout-flow\">\n<a href=\"\/public\/sod-chapter-2-subchapter-3\">\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"212\" src=\"https:\/\/schizophrenia.life\/public\/wp-content\/uploads\/2025\/09\/2.3.jpg\" alt=\"\" class=\"wp-image-6058\"\/><\/figure>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-12a3514a68280dc9b4a065b8835c13dc wp-block-paragraph\" style=\"font-size:16px\"><strong>Subchapter 3.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"font-size:16px\">Dual schizophrenia impacts overall health<\/p>\n\n\n\n<\/a>\n<\/div>\n\n\n\n<div class=\"wp-block-column sod-column sod-column-e3ce6f is-layout-flow wp-block-column-is-layout-flow\">\n<a href=\"\/public\/sod-chapter-2-subchapter-4\">\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"212\" src=\"https:\/\/schizophrenia.life\/public\/wp-content\/uploads\/2025\/09\/2.4.jpg\" alt=\"\" class=\"wp-image-6059\"\/><\/figure>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-8a55d440301199ef623641acd46cc15f wp-block-paragraph\" style=\"font-size:16px\"><strong>Subchapter 4.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"font-size:16px\">Does substance use impact the effectiveness of schizophrenia treatment?<\/p>\n\n\n\n<\/a>\n<\/div>\n<\/div>\n\n\n\n<div class=\"custom-css-block\"><style>#aab_accordion_d0ec9df8_0 {  }<\/style><\/div><div class=\"wp-block-aab-accordion-block aab__accordion_container  accessibilityOn\" style=\"margin-top:0px;margin-bottom:15px;border:1px solid #bcb6b638\" id=\"aab_accordion_d0ec9df8_0\" role=\"button\" aria-expanded=\"false\" tabindex=\"0\"><div class=\"aab__accordion_head aab_right_icon \" style=\"background-color:#bcb6b638;border-top:none;border-right:none;border-bottom:none;border-left:none\"><div class=\"aab__accordion_heading aab_right_icon aab_right_link\"><div class=\"head_content_wrapper\"><div class=\"title_wrapper\"><h5 class=\"aab__accordion_title\" style=\"margin:0\">References<\/h5><\/div><\/div><\/div><div class=\"aab__accordion_icon\" style=\"border:0px solid transparent\"><span class=\"aab__icon dashicons dashicons-plus-alt2\" style=\"font-size:23px\"><\/span><\/div><\/div><div class=\"aab__accordion_body  \" role=\"region\" style=\"display:none;border-top:1px solid #bcb6b638;border-right:none;border-bottom:none;border-left:none\"><div class=\"aab__accordion_component\">\n<div class=\"wp-block-rea-list-rea-list-block rea-list-block front\"><div class=\"rea-list-block__wrapper\"><div class=\"list-ordered list\"><p>Peris L, Szerman N. Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia. Frontiers in Psychiatry [Internet]. 2021 Dec 16;12:769623. Available from: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8716462\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8716462\/<\/a><\/p><p>Negrete JC. Clinical Aspects of Substance Abuse in Persons with Schizophrenia. The Canadian Journal of Psychiatry [Internet]. 2003 Feb [cited 2025 Jul 10];48(1):14\u201321. Available from: <a href=\"https:\/\/journals.sagepub.com\/doi\/10.1177\/070674370304800104\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/journals.sagepub.com\/doi\/10.1177\/070674370304800104<\/a><\/p><p>Brady KT, Kalin NH. Substance Use Disorders: Confronting Addiction From Prevention to Recovery. American Journal of Psychiatry [Internet]. 2024 May 1;181(5):347\u20138. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38706333\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38706333\/<\/a><\/p><p>Masroor A, Khorochkov A, Prieto J, Singh KB, Nnadozie MC, Abdal M, et al. Unraveling the Association Between Schizophrenia and Substance Use Disorder-Predictors, Mechanisms and Treatment Modifications: A Systematic Review. Cureus [Internet]. 2021 Jul 29;13(7). Available from: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8405179\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8405179\/<\/a><\/p><p>Nathan R, Lewis E. Assessment of coexisting psychosis and substance misuse: complexities, challenges and causality. BJPsych Advances [Internet]. 2020 Jul 20;27(1):1\u201311. Available from: <a href=\"https:\/\/www.cambridge.org\/core\/journals\/bjpsych-advances\/article\/assessment-of-coexisting-psychosis-and-substance-misuse-complexities-challenges-and-causality\/AA565FFAE9E4F283AD6398447A226198\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.cambridge.org\/core\/journals\/bjpsych-advances\/article\/assessment-of-coexisting-psychosis-and-substance-misuse-complexities-challenges-and-causality\/AA565FFAE9E4F283AD6398447A226198<\/a><\/p><p>Lundin NB, Blouin AM, Cowan HR, Moe AM, Wastler HM, Breitborde NJ. Identification of Psychosis Risk and Diagnosis of First-Episode Psychosis: Advice for Clinicians. Psychology Research and Behavior Management [Internet]. 2024 Mar 21;17:1365\u201383. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38529082\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38529082\/<\/a><\/p><p>DSM-V: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edn). APA, 2013.<\/p><p>Wilson L, Szigeti A, Kearney A, Clarke M. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review. Schizophrenia Research [Internet]. 2018 Jul;197:78\u201386. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29117908\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29117908\/<\/a><\/p><p>Sulzer D. How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission. Neuron [Internet]. 2011 Feb;69(4):628\u201349. Available from: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3065181\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3065181\/<\/a><\/p><p>Beckmann D, Lowman KL, Nargiso J, McKowen J, Watt L, Yule AM. Substance- induced Psychosis in Youth. Child and Adolescent Psychiatric Clinics of North America [Internet]. 2020 Jan;29(1):131\u201343. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31708042\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31708042\/<\/a><\/p><p>Vassos E. What Is the Link between Substance- Induced Psychosis and Primary Psychotic Disorders? The American Journal of Psychiatry [Internet]. 2023 Jun 1;180(6):404\u20136. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37259511\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/37259511\/<\/a><\/p><p>Starzer MSK, Nordentoft M, Hjorth\u00f8j C. Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis. American Journal of Psychiatry [Internet]. 2018 Apr;175(4):343\u201350. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29179576\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29179576\/<\/a><\/p><p>Subodh BN, Sahoo S, Basu D, Mattoo SK. Age of onset of substance use in patients with dual diagnosis and its association with clinical characteristics, risk behaviors, course, and outcome: A retrospective study. Indian Journal of Psychiatry [Internet]. 2019;61(4):359\u201368. Available from: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6657549\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6657549\/<\/a><\/p><p>Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, et al. Substance use in individuals at clinical high risk of psychosis. Psychological Medicine [Internet]. 2015 Mar 2;45(11):2275\u201384. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25727300\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/25727300\/<\/a><\/p><p>McHugh MJ, McGorry PD, Yuen HP, Hickie IB, Thompson A, de Haan L, et al. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo. Schizophrenia Research [Internet]. 2018 May;195:543\u20138. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29055567\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29055567\/<\/a><\/p><p>Nawi AM, Ismail R, Ibrahim F, Hassan MR, Manaf MRA, Amit N, et al. Risk and protective factors of drug abuse among adolescents: A systematic review. BMC Public Health [Internet]. 2021 Nov 13;21(1). Available from: <a href=\"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11906-2\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11906-2<\/a><\/p><p>Hjorth\u00f8j C, St\u00fcrup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. The Lancet Psychiatry [Internet]. 2017 Apr;4(4):295\u2013301. Available from: <a href=\"https:\/\/www.thelancet.com\/journals\/lanpsy\/article\/PIIS2215-0366(17)30078-0\/fulltext\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.thelancet.com\/journals\/lanpsy\/article\/PIIS2215-0366(17)30078-0\/fulltext<\/a><\/p><p>Pizzol D, Trott M, Butler L, Barnett Y, Ford T, Neufeld SA, et al. Relationship between severe mental illness and physical multimorbidity: A meta-analysis and call for action. BMJ Mental Health [Internet]. 2023 Oct 1;26(1). Available from: <a href=\"https:\/\/mentalhealth.bmj.com\/content\/26\/1\/e300870\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/mentalhealth.bmj.com\/content\/26\/1\/e300870<\/a><\/p><p>Skarstein S, Lien L, Abebe DS. The burden of somatic diseases among people with alcohol- and drug use disorders are influenced by mental illness and low socioeconomic status. A registry-based cohort study in Norway. Journal of Psychosomatic Research [Internet]. 2023 Feb;165:111137. Available from: <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022399922004226?via%3Dihub\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022399922004226?via%3Dihub<\/a><\/p><p>Szerman N, Torrens M, Maldonado R, Balhara YPS, Salom C, Maremmani I, et al. Addictive and other mental disorders: a call for a standardized definition of dual disorders. Translational Psychiatry [Internet]. 2022 Oct 13;12(1). Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36229453\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/36229453\/<\/a><\/p><p>Guo J, Lv X, Liu Y, Kong L, Qu H, Yue W. Influencing factors of medication adherence in schizophrenic patients: a meta- analysis. Schizophrenia [Internet]. 2023;9(1):1\u20138. Available from: <a href=\"https:\/\/www.nature.com\/articles\/s41537-023-00356-x\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.nature.com\/articles\/s41537-023-00356-x<\/a><\/p><p>Rivelli A, Fitzpatrick V, Nelson M, Laubmeier K, Zeni C, Mylavarapu S. Real-world predictors of relapse in patients with schizophrenia and schizoaffective disorder in a large health system. Schizophrenia [Internet]. 2024 Feb 29;10(1):28. Available from: <a href=\"https:\/\/www.nature.com\/articles\/s41537-024-00448-2\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.nature.com\/articles\/s41537-024-00448-2<\/a><\/p><p>Swendsen J, Ben-Zeev D, Granholm E. Real-Time Electronic Ambulatory Monitoring of Substance Use and Symptom Expression in Schizophrenia. American Journal of Psychiatry [Internet]. 2011 Feb;168(2):202\u20139. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21078705\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/21078705\/<\/a><\/p><p>Bahorik AL, Newhill CE, Queen CC, Eack SM. Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors. Psychological Medicine [Internet]. 2013 Apr 3;44(1):61\u20139. Available from: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23551851\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/pubmed.ncbi.nlm.nih.gov\/23551851\/<\/a><\/p><p>Barlati S, Nibbio G, Vita A. Evidence-based Psychosocial Interventions in schizophrenia: a Critical Review. Current opinion in psychiatry [Internet]. 2024 Feb 15;37(3). Available from: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10990032\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10990032\/<\/a><\/p><\/div><\/div><\/div>\n<\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Chapter 2 Facing dual challenge This chapter highlights the key clinical aspects of schizophrenia and substance use disorders, with a focus on their co-occurrence and the challenges they present, and the importance of integrated therapies that address both illnesses. Download the chapter Fast Facts Early onset: People with schizophrenia 43 and a history of substance [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-sod.php","meta":{"_acf_changed":false,"rea_page_title_signed_in_meta_block_field":"","rea_page_title_signed_out_meta_block_field":"","rea_page_description_signed_in_meta_block_field":"","rea_page_description_signed_out_meta_block_field":"","rea_page_footer_id_meta_block_field":"","rea_page_footer_date_meta_block_field":"","footnotes":""},"class_list":["post-5165","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/schizophrenia.life\/public\/wp-json\/wp\/v2\/pages\/5165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/schizophrenia.life\/public\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/schizophrenia.life\/public\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/schizophrenia.life\/public\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/schizophrenia.life\/public\/wp-json\/wp\/v2\/comments?post=5165"}],"version-history":[{"count":0,"href":"https:\/\/schizophrenia.life\/public\/wp-json\/wp\/v2\/pages\/5165\/revisions"}],"wp:attachment":[{"href":"https:\/\/schizophrenia.life\/public\/wp-json\/wp\/v2\/media?parent=5165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}